BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35811752)

  • 1. Newly implemented community CD4 service in Tshwaragano, Northern Cape province, South Africa, positively impacts result turn-around time.
    Coetzee LM; Cassim N; Glencross DK
    Afr J Lab Med; 2022; 11(1):1376. PubMed ID: 35811752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.
    Cassim N; Coetzee LM; Schnippel K; Glencross DK
    PLoS One; 2014; 9(12):e115420. PubMed ID: 25517412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a new 'community' laboratory CD4 service in a rural health district in South Africa extends laboratory services and substantially improves local reporting turnaround time.
    Coetzee LM; Cassim N; Glencross DK
    S Afr Med J; 2015 Dec; 106(1):82-7. PubMed ID: 26792313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme.
    Glencross DK; Coetzee LM; Cassim N
    PLoS One; 2014; 9(12):e114727. PubMed ID: 25490718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly laboratory turn-around time identifies poor performance masked by aggregated reporting.
    Coetzee LM; Cassim N; Glencross DK
    Afr J Lab Med; 2020; 9(1):1102. PubMed ID: 33392052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Categorising specimen referral delays for CD4 testing: How inter-laboratory distances and travel times impact turn-around time across a national laboratory service in South Africa.
    Cassim N; Coetzee LM; Glencross DK
    Afr J Lab Med; 2020; 9(1):1120. PubMed ID: 33392053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timely delivery of laboratory efficiency information, Part II: Assessing the impact of a turn-around time dashboard at a high-volume laboratory.
    Cassim N; Coetzee LM; Tepper MEE; Perelson L; Glencross DK
    Afr J Lab Med; 2020; 9(2):948. PubMed ID: 32391245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using laboratory data to categorise CD4 laboratory turn-around-time performance across a national programme.
    Coetzee LM; Cassim N; Glencross DK
    Afr J Lab Med; 2018; 7(1):665. PubMed ID: 30167387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays in HIV-1 infant polymerase chain reaction testing may leave children without confirmed diagnoses in the Western Cape province, South Africa.
    Mahlakwane KL; Preiser W; Nkosi N; Naidoo N; van Zyl G
    Afr J Lab Med; 2022; 11(1):1485. PubMed ID: 35811753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth investigation of turn-around time of full blood count tests requested from a clinical haematology outpatient department in Cape Town, South Africa.
    Mutema L; Chapanduka Z; Musaigwa F; Mashigo N
    Afr J Lab Med; 2021; 10(1):1318. PubMed ID: 34007817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
    Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
    PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost-per-result of a national reflexed Cryptococcal antigenaemia screening program: Forecasting the impact of potential HIV guideline changes and treatment goals.
    Cassim N; Coetzee LM; Schnippel K; Glencross DK
    PLoS One; 2017; 12(8):e0182154. PubMed ID: 28829788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of HIV disease burden by calculating the percentages of patients with CD4 counts <100 cells/µL across 52 districts reveals hot spots for intensified commitment to programmatic support.
    Coetzee LM; Cassim N; Glencross DK
    S Afr Med J; 2017 May; 107(6):507-513. PubMed ID: 28604323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the Prevention of Mother-to-Child Transmission (PMTCT) Program in the Northern Cape, South Africa.
    Myburgh B; Nel R; Lategan-Potgieter R
    Curr HIV Res; 2017; 15(1):38-45. PubMed ID: 28002994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling CD4 reagent usage across a national hierarchal network of laboratories in South Africa.
    Cassim N; Coetzee LM; Glencross DK
    Afr J Lab Med; 2023; 12(1):2085. PubMed ID: 37293320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that Influence Teenage Antenatal Care Utilization in John Taolo Gaetsewe (JTG) District of Northern Cape Province, South Africa: Underscoring the Need for Tackling Social Determinants of Health.
    Worku EB; Woldesenbet SA
    Int J MCH AIDS; 2016; 5(2):134-145. PubMed ID: 28058200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timely delivery of laboratory efficiency information, Part I: Developing an interactive turnaround time dashboard at a high-volume laboratory.
    Cassim N; Tepper ME; Coetzee LM; Glencross DK
    Afr J Lab Med; 2020; 9(2):947. PubMed ID: 32391244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.
    Gil M; Ramil F; AgÍs JA
    Zootaxa; 2020 Nov; 4878(3):zootaxa.4878.3.2. PubMed ID: 33311142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of care provided by a public sector STD clinic in Cape Town.
    Mathews C; van Rensburg A; Schierhout G; Coetzee N; Lombard CJ; Fehler HG; Ballard RC
    Int J STD AIDS; 1998 Nov; 9(11):689-94. PubMed ID: 9863583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in syphilis seroprevalence among females of reproductive age in Northern Cape Province, South Africa, 2003-2012: utility of laboratory-based information.
    Ballah NJ; Kuonza LR; De Gita G; Musekiwa A; Williams S; Takuva S
    Int J STD AIDS; 2017 May; 28(6):564-572. PubMed ID: 26924504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.